These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 29063666)

  • 1. Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.
    Yamaguchi Y; Kanzaki H; Katsumata Y; Itohiya K; Fukaya S; Miyamoto Y; Narimiya T; Wada S; Nakamura Y
    J Cell Mol Med; 2018 Feb; 22(2):1138-1147. PubMed ID: 29063666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice.
    Kanzaki H; Shinohara F; Itohiya K; Yamaguchi Y; Katsumata Y; Matsuzawa M; Fukaya S; Miyamoto Y; Wada S; Nakamura Y
    FASEB J; 2017 Feb; 31(2):781-792. PubMed ID: 27836987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Nrf2 induction by protein transduction attenuates osteoclastogenesis.
    Kanzaki H; Shinohara F; Kajiya M; Fukaya S; Miyamoto Y; Nakamura Y
    Free Radic Biol Med; 2014 Dec; 77():239-48. PubMed ID: 25224039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling.
    Thummuri D; Naidu VGM; Chaudhari P
    J Mol Med (Berl); 2017 Oct; 95(10):1065-1076. PubMed ID: 28674855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling.
    Ni S; Qian Z; Yuan Y; Li D; Zhong Z; Ghorbani F; Zhang X; Zhang F; Zhang Z; Liu Z; Yu B
    Cell Prolif; 2020 Oct; 53(10):e12882. PubMed ID: 32871020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.
    Kanzaki H; Shinohara F; Kajiya M; Kodama T
    J Biol Chem; 2013 Aug; 288(32):23009-20. PubMed ID: 23801334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sargassum serratifolium attenuates RANKL-induced osteoclast differentiation and oxidative stress through inhibition of NF-κB and activation of the Nrf2/HO-1 signaling pathway.
    Kim HJ; Park C; Kim GY; Park EK; Jeon YJ; Kim S; Hwang HJ; Choi YH
    Biosci Trends; 2018; 12(3):257-265. PubMed ID: 30012915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 activation attenuates both orthodontic tooth movement and relapse.
    Kanzaki H; Shinohara F; Itohiya-Kasuya K; Ishikawa M; Nakamura Y
    J Dent Res; 2015 Jun; 94(6):787-94. PubMed ID: 25795629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
    Hong SE; Lee J; Seo DH; In Lee H; Ri Park D; Lee GR; Jo YJ; Kim N; Kwon M; Shon H; Kyoung Seo E; Kim HS; Young Lee S; Jeong W
    Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
    Chen D; Ye Z; Wang C; Wang Q; Wang H; Kuek V; Wang Z; Qiu H; Yuan J; Kenny J; Yang F; He J; Liu Y; Wang G; Zhang M; Zhang G; Wang J; Chen P; Xu J
    Pharmacol Res; 2020 Sep; 159():104944. PubMed ID: 32454224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bach1 Inhibition Suppresses Osteoclastogenesis via Reduction of the Signaling via Reactive Oxygen Species by Reinforced Antioxidation.
    Wada S; Kanzaki H; Katsumata Y; Yamaguchi Y; Narimiya T; Attucks OC; Nakamura Y; Tomonari H
    Front Cell Dev Biol; 2020; 8():740. PubMed ID: 32850850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.
    Xue P; Hu X; Powers J; Nay N; Chang E; Kwon J; Wong SW; Han L; Wu TH; Lee DJ; Tseng H; Ko CC
    Biochem Biophys Res Commun; 2019 Apr; 511(3):637-643. PubMed ID: 30826055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhizin Suppresses RANKL-Induced Osteoclastogenesis and Oxidative Stress Through Inhibiting NF-κB and MAPK and Activating AMPK/Nrf2.
    Li Z; Chen C; Zhu X; Li Y; Yu R; Xu W
    Calcif Tissue Int; 2018 Sep; 103(3):324-337. PubMed ID: 29721581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
    Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
    Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells.
    Liu M; Liu S; Zhang Q; Fang Y; Yu Y; Zhu L; Liu Y; Gong W; Zhao L; Qin L; Zhang Q
    J Ethnopharmacol; 2021 Jul; 275():114129. PubMed ID: 33878416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
    Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
    PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species.
    Kondo H; Takeuchi S; Togari A
    Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E507-15. PubMed ID: 23169789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response.
    Xue P; Hu X; Chang E; Wang L; Chen M; Wu TH; Lee DJ; Foster BL; Tseng HC; Ko CC
    Exp Mol Med; 2021 Apr; 53(4):667-680. PubMed ID: 33864025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-1225 activates Keap1-Nrf2-HO-1 signalling to inhibit TNFα-induced osteoclastogenesis by mediating ROS generation.
    Reziwan K; Sun D; Zhang B; Zhao Z
    Cell Biochem Funct; 2019 Jun; 37(4):256-265. PubMed ID: 31017694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.